Back

Personalised antithrombotic therapy after atrial fibrillation ablation

28 August 2026 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Challenges with antithrombotic strategies in atrial fibrillation and coronary disease: time to personalise? Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Renate B Schnabel

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
When to consider left atrial appendage occlusion
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Can we stop anticoagulation after successful atrial fibrillation ablation?
Doctor V. Markides (London, GB)
Slides Video
Presentation thumbnail
Novel antithrombotic strategies in atrial fibrillation: time to personalise? - patient perspective
Mr M. Madigan (Dublin, IE)
Slides Video

Access the full session

Session thumbnail
Challenges with antithrombotic strategies in atrial fibrillation and coronary disease: time to personalise?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Rethinking anticoagulation: challenges in assessing stroke risk in atrial fibrillation patients with low CHADS-VASc scores
29 August 2025
thumbnail
Congress Presentation
Can we stop oral anticoagulation after successful atrial fibrillation ablation?: con
30 August 2026
thumbnail
Congress Presentation
Risk factors of atrial arrhythmia recurrence and impact on the benefit of oral anticoagulation discontinuation: insights from the ALONE-AF trial
29 August 2026
thumbnail
Congress Session
Personalised anticoagulation therapy in eligible patients with atrial fibrillation
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources